8,059
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Deucravacitinib in the treatment of psoriasis

, ORCID Icon & ORCID Icon
Article: 2154122 | Received 10 Oct 2022, Accepted 29 Nov 2022, Published online: 13 Dec 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Luca Potestio, Angelo Ruggiero, Gabriella Fabbrocini, Fabrizio Martora & Matteo Megna. (2023) Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature. Psoriasis: Targets and Therapy 13, pages 19-26.
Read now

Articles from other publishers (3)

Shymaa Hatem & Maha El-Kayal. (2023) Novel anti-psoriatic nanostructured lipid carriers for the cutaneous delivery of luteolin: A comprehensive in-vitro and in-vivo evaluation. European Journal of Pharmaceutical Sciences 191, pages 106612.
Crossref
Paloma Seidel & Nina Magnolo. (2023) Psoriasis: eine Systemerkrankung mit multiplen Behandlungsoptionen. ästhetische dermatologie & kosmetologie 15:4, pages 34-41.
Crossref
Sarah Oliel, Sarah Moussa, Monica Stanciu & Elena Netchiporouk. (2023) Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report. SAGE Open Medical Case Reports 11.
Crossref